These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 28317644)

  • 1. The biomarker-based diagnosis of Alzheimer's disease. 1-ethical and societal issues.
    Porteri C; Albanese E; Scerri C; Carrillo MC; Snyder HM; Martensson B; Baker M; Giacobini E; Boccardi M; Winblad B; Frisoni GB; Hurst S;
    Neurobiol Aging; 2017 Apr; 52():132-140. PubMed ID: 28317644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of the Ethical Issues of a Biomarker-Based Diagnoses in the Early Stage of Alzheimer's Disease.
    Vanderschaeghe G; Dierickx K; Vandenberghe R
    J Bioeth Inq; 2018 Jun; 15(2):219-230. PubMed ID: 29532386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethical Arguments Concerning the Use of Alzheimer's Disease Biomarkers in Individuals with No or Mild Cognitive Impairment: A Systematic Review and Framework for Discussion.
    Smedinga M; Tromp K; Schermer MHN; Richard E
    J Alzheimers Dis; 2018; 66(4):1309-1322. PubMed ID: 30507575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and management of Alzheimer's disease: past, present and future ethical issues.
    Gauthier S; Leuzy A; Racine E; Rosa-Neto P
    Prog Neurobiol; 2013 Nov; 110():102-13. PubMed ID: 23578568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].
    Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ;
    Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarker-based diagnosis of mild cognitive impairment due to Alzheimer's disease: how and what to tell. A kickstart to an ethical discussion.
    Porteri C; Frisoni GB
    Front Aging Neurosci; 2014; 6():41. PubMed ID: 24678299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Views on Early Diagnosis of Alzheimer's Disease Among Dutch Physicians: A Qualitative Interview Study.
    Tromp K; Smedinga M; Richard E; Perry M; Schermer MHN
    J Alzheimers Dis; 2021; 79(2):917-927. PubMed ID: 33361592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Considerations regarding a diagnosis of Alzheimer's disease before dementia: a systematic review.
    van der Schaar J; Visser LNC; Bouwman FH; Ket JCF; Scheltens P; Bredenoord AL; van der Flier WM
    Alzheimers Res Ther; 2022 Feb; 14(1):31. PubMed ID: 35144684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The strategic biomarker roadmap for the validation of Alzheimer's diagnostic biomarkers: methodological update.
    Boccardi M; Dodich A; Albanese E; Gayet-Ageron A; Festari C; Ashton NJ; Bischof GN; Chiotis K; Leuzy A; Wolters EE; Walter MA; Rabinovici GD; Carrillo M; Drzezga A; Hansson O; Nordberg A; Ossenkoppele R; Villemagne VL; Winblad B; Frisoni GB; Garibotto V
    Eur J Nucl Med Mol Imaging; 2021 Jul; 48(7):2070-2085. PubMed ID: 33688996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction and Early Detection of Alzheimer's Dementia: Professional Disclosure Practices and Ethical Attitudes.
    Schweda M; Kögel A; Bartels C; Wiltfang J; Schneider A; Schicktanz S
    J Alzheimers Dis; 2018; 62(1):145-155. PubMed ID: 29439325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The controversy over early diagnosis of Alzheimer's disease: A literature review of the advantages and disadvantages].
    Gräßel E; Lauer N
    Z Evid Fortbild Qual Gesundhwes; 2023 Jun; 179():95-105. PubMed ID: 37263875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of biomarkers to chart all Alzheimer's disease stages: the royal road to cutting the therapeutic Gordian Knot.
    Hampel H; Lista S; Khachaturian ZS
    Alzheimers Dement; 2012 Jul; 8(4):312-36. PubMed ID: 22748938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative.
    Molinuevo JL; Blennow K; Dubois B; Engelborghs S; Lewczuk P; Perret-Liaudet A; Teunissen CE; Parnetti L
    Alzheimers Dement; 2014 Nov; 10(6):808-17. PubMed ID: 25150736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. European Academy of Neurology/European Alzheimer's Disease Consortium position statement on diagnostic disclosure, biomarker counseling, and management of patients with mild cognitive impairment.
    Frederiksen KS; Nielsen TR; Winblad B; Schmidt R; Kramberger MG; Jones RW; Hort J; Grimmer T; Georges J; Frölich L; Engelborghs S; Dubois B; Waldemar G
    Eur J Neurol; 2021 Jul; 28(7):2147-2155. PubMed ID: 33368924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New diagnostic guidelines for Alzheimer's disease by NIA/AA].
    Ihara R
    Nihon Rinsho; 2016 Mar; 74(3):386-94. PubMed ID: 27025074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment.
    Herukka SK; Simonsen AH; Andreasen N; Baldeiras I; Bjerke M; Blennow K; Engelborghs S; Frisoni GB; Gabryelewicz T; Galluzzi S; Handels R; Kramberger MG; Kulczyńska A; Molinuevo JL; Mroczko B; Nordberg A; Oliveira CR; Otto M; Rinne JO; Rot U; Saka E; Soininen H; Struyfs H; Suardi S; Visser PJ; Winblad B; Zetterberg H; Waldemar G
    Alzheimers Dement; 2017 Mar; 13(3):285-295. PubMed ID: 28341066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of Cognitive Impairment Compatible with Early Diagnosis of Alzheimer's Disease. A Bayesian Network Model based on the Analysis of Oral Definitions of Semantic Categories.
    Guerrero JM; Martínez-Tomás R; Rincón M; Peraita H
    Methods Inf Med; 2016; 55(1):42-9. PubMed ID: 25925692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.
    Vos SJ; Verhey F; Frölich L; Kornhuber J; Wiltfang J; Maier W; Peters O; Rüther E; Nobili F; Morbelli S; Frisoni GB; Drzezga A; Didic M; van Berckel BN; Simmons A; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Lovestone S; Muscio C; Herukka SK; Salmon E; Bastin C; Wallin A; Nordlund A; de Mendonça A; Silva D; Santana I; Lemos R; Engelborghs S; Van der Mussele S; ; Freund-Levi Y; Wallin ÅK; Hampel H; van der Flier W; Scheltens P; Visser PJ
    Brain; 2015 May; 138(Pt 5):1327-38. PubMed ID: 25693589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New clinical criteria for the Alzheimer's disease spectrum.
    Petersen RC
    Minn Med; 2012 Jan; 95(1):42-5. PubMed ID: 22355912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease.
    Haris M; Yadav SK; Rizwan A; Singh A; Cai K; Kaura D; Wang E; Davatzikos C; Trojanowski JQ; Melhem ER; Marincola FM; Borthakur A
    Neuroimage Clin; 2015; 7():598-604. PubMed ID: 25844314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.